{'fraction_non_alphanumeric': 0.03727959697732997, 'fraction_numerical': 0.01662468513853904, 'mean_word_length': 5.469055374592834, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 years old with Type 1 Diabetes.

AIM
There are multiple information sources available to assist families in learning about rapidly advancing diabetes technologies as care options for their children. The current study explored where and from whom families of young children with type 1 diabetes get information about diabetes technologies and the valence (positive vs. negative) of that information.


METHODS
Semi-structured interviews were conducted with parents (86% mothers) of 79 youth <8 years old with type 1 diabetes for ≥6 months, ([M±SD] age 5.2±1.5 years, diabetes duration 2.4±1.3 years, 77% white, A1c 63±10 mmol/mol (7.9±0.9%), 66% pump-treated, 58% using continuous glucose monitors (CGM). Interviews were transcribed and underwent content analysis to derive central themes.


RESULTS
Most parents reported learning about new technologies from three direct sources: diabetes care providers, people with diabetes, and caregivers of children with diabetes. Parents also cited three indirect sources of information: online forums, publications, and diabetes-specific conferences. Parents reported hearing primarily positive things about technologies. Families not using pump and/or CGM noted reluctance to use technology due to family-specific concerns (e.g., cost, child's unwillingness to wear device) rather than information from outside sources. In this subset of parents, many still expressed willingness to initiate use once family-specific concerns were resolved.


CONCLUSIONS
Parents of young children received largely positive information about diabetes technologies, primarily from healthcare providers and others familiar with using devices personally or for their children. To maximize diabetes technology use in young children, it is incumbent upon providers to ensure families receive balanced, realistic information about benefits and barriers.